Application Note: Developing viral vaccines for emerging infectious diseases
26 November 2020
The recent global outbreak of a novel pandemic COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), reminds us of the constant need for continued vaccine development as viral threats evolve. Unprecedented efforts and collaborations in the scientific community are underway to develop a vaccine. See how Sartorius’ innovative solutions advance and accelerate discovery and development of new vaccines against viral infections.